MainPage Create-article | Edit-article DomainTool Back ParentDir HybridLangList

  • More(506:0) || ALL >book >Journals >The New England Journal of Medicine

  • LinkedIn Login, Sign in | LinkedIn 100 2022-05-27 19:14:45 charles888
    My Account - Sign In 100 2022-05-27 19:11:46 charles888
    Massachusetts Medical Society | Careers 100 2022-05-27 18:56:10 charles888
    Audio Interview: Waning Immunity against Covid-19 | NEJM 100 2022-05-27 13:01:24 charles888
    CME credit and exams: The New England Journal of Medicine 100 2022-05-27 12:56:38 charles888
    CME credit and exams: The New England Journal of Medicine 100 2022-05-27 12:56:19 charles888
    CME credit and exams: The New England Journal of Medicine 100 2022-05-27 12:55:59 charles888
    Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 | NEJM 100 2022-05-27 12:53:22 charles888
    Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron | NEJM 100 2022-05-27 12:52:59 charles888
    Tranexamic Acid in Noncardiac Surgery | NEJM 100 2022-05-27 12:49:06 charles888
    NEJM — Gray Matters: Analysis and Ambiguity 100 2022-05-27 12:37:13 charles888
    Medicine and Society Articles: The New England Journal of Medicine 100 2022-05-27 12:36:52 charles888
    Health Policy — The New England Journal of Medicine 100 2022-05-27 12:36:32 charles888
    Clinical Practice Topics: The New England Journal of Medicine 100 2022-05-27 12:36:12 charles888
    Surgery articles: The New England Journal of Medicine 100 2022-05-27 12:35:52 charles888
    Rheumatology articles: The New England Journal of Medicine 100 2022-05-27 12:35:31 charles888
    Obstetrics/Gynecology articles: The New England Journal of Medicine 100 2022-05-27 12:33:54 charles888
    Neurology/Neurosurgery articles: The New England Journal of Medicine 100 2022-05-27 12:33:33 charles888
    Nephrology articles: The New England Journal of Medicine 100 2022-05-27 12:33:12 charles888
    Infectious disease articles: The New England Journal of Medicine 100 2022-05-27 12:32:51 charles888
    Genetics articles: The New England Journal of Medicine 100 2022-05-27 12:31:20 charles888
    Gastroenterology articles: The New England Journal of Medicine 100 2022-05-27 12:31:01 charles888
    Endocrinology articles: The New England Journal of Medicine 100 2022-05-27 12:30:39 charles888
    Emergency medicine articles: The New England Journal of Medicine 100 2022-05-27 12:30:18 charles888
    Dermatology articles: The New England Journal of Medicine 100 2022-05-27 12:29:59 charles888
    Clinical Medicine 100 2022-05-27 12:29:39 charles888
    Cardiology articles: The New England Journal of Medicine 100 2022-05-27 12:29:18 charles888
    Allergy/Immunology articles: The New England Journal of Medicine 100 2022-05-27 12:28:57 charles888
    Medical Specialties: The New England Journal of Medicine 100 2022-05-27 12:28:35 charles888
    NEJM Subscribe 100 2022-05-27 12:28:15 charles888
    Sign In | NEJM 100 2022-05-27 12:27:36 charles888
    Renew 100 2022-05-27 12:26:31 charles888
    Home - NEJM Library Hub 100 2022-05-27 12:25:11 charles888
    NEJM CareerCenter | jobs | Choose from 11,836 live job openings 100 2022-05-27 12:24:52 charles888
    NEJM Healer 100 2022-05-27 12:24:21 charles888
    What's New | NEJM Resident 360 100 2022-05-27 12:24:03 charles888
    NEJM Knowledge+ - Home 100 2022-05-27 12:23:41 charles888
    About NEJM Catalyst 100 2022-05-27 12:23:06 charles888
    Clinical Trials Research | NEJM Evidence 100 2022-05-27 12:22:48 charles888
    NEJM Group 100 2022-05-27 12:22:28 charles888
    NEJM Catalyst - Home - Practical Innovations in Health Care Delivery 100 2022-05-24 08:09:29 charles888
    Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study - PubMed 100 2022-05-24 08:03:33 charles888
    Firearm purchasing and firearm violence during the coronavirus pandemic in the United States: a cross-sectional study | Injury Epidemiology | Full Text 100 2022-05-24 08:03:13 charles888
    The Major Causes of Death in Children and Adolescents in the United States - PubMed 100 2022-05-24 08:02:41 charles888
    Current Epidemiological Trends in Firearm Mortality in the United States - PubMed 100 2022-05-24 08:01:51 charles888
    Current Epidemiological Trends in Firearm Mortality in the United States | Firearms | JAMA Psychiatry | JAMA Network 100 2022-05-24 08:01:09 charles888
    US Firearm-Related Mortality: National, State, And Population Trends, 1999-2017 - PubMed 100 2022-05-24 08:00:46 charles888
    Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021 - PubMed 100 2022-05-24 07:28:54 charles888
    Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021 - PubMed 100 2022-05-24 07:27:46 charles888
    An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status - PubMed 100 2022-05-24 07:26:52 charles888
    ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections - PubMed 100 2022-05-24 07:25:40 charles888
    Immunity after SARS-CoV-2 infections - PubMed 100 2022-05-24 07:24:54 charles888
    Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 - PubMed 100 2022-05-24 07:22:51 charles888
    Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 | Nature 100 2022-05-24 07:22:16 charles888
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant - PubMed 100 2022-05-24 07:14:42 charles888
    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies - PubMed 100 2022-05-24 07:13:53 charles888
    Waning Immunity after the BNT162b2 Vaccine in Israel - PubMed 100 2022-05-24 07:12:14 charles888
    COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study - PubMed 100 2022-05-24 07:08:41 charles888
    Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study - PubMed 100 2022-05-24 07:07:54 charles888
    Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ 100 2022-05-24 07:07:17 charles888
    COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021 - PubMed 100 2022-05-24 07:01:47 charles888
    COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021 | MMWR 100 2022-05-24 07:01:27 charles888
    Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors - PubMed 100 2022-05-24 06:50:23 charles888
    Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events - PubMed 100 2022-05-24 06:49:50 charles888
    Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events | Signal Transduction and Targeted Therapy 100 2022-05-24 06:49:30 charles888
    NEJM Media Center 100 2022-05-24 06:37:59 charles888
    NEJM Review CME Program | NEJM 100 2022-05-24 06:37:20 charles888
    NEJM Weekly CME Program 100 2022-05-24 06:37:00 charles888
    Access in Low-Income Countries | About NEJM 100 2022-05-24 06:36:39 charles888
    Online Access Levels | About NEJM 100 2022-05-24 06:36:20 charles888
    Article Metrics | About NEJM 100 2022-05-24 06:35:48 charles888
    NEJM Group at Medical Meetings | About NEJM 100 2022-05-24 06:34:52 charles888
    Editorial Policies | About NEJM 100 2022-05-24 06:34:31 charles888
    Information for Subscription Agents | NEJM 100 2022-05-24 02:32:17 charles888
    Molnupiravir for Covid-19 in Nonhospitalized Patients | NEJM 100 2022-05-24 02:28:48 charles888
    Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City - PubMed 100 2022-05-24 02:25:57 charles888
    Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City | Open Forum Infectious Diseases | Oxford Academic 100 2022-05-24 02:25:17 charles888
    Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants - PubMed 100 2022-05-24 02:24:55 charles888
    Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants | Open Forum Infectious Diseases | Oxford Academic 100 2022-05-24 02:24:33 charles888
    Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial - PubMed 100 2022-05-24 02:24:11 charles888
    Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalization - Five Veterans Affairs Medical Centers, United States, February 1-August 6, 2021 - PubMed 100 2022-05-24 02:23:22 charles888
    Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020 - PubMed 100 2022-05-24 02:21:37 charles888
    Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020 | MMWR 100 2022-05-24 02:21:03 charles888
    Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults | NEJM Evidence 100 2022-05-24 02:20:40 charles888
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021 - PubMed 100 2022-05-24 02:20:20 charles888
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021 | MMWR 100 2022-05-24 02:19:45 charles888
    Group sequential designs using a family of type I error probability spending functions - PubMed 100 2022-05-24 02:19:21 charles888
    Comparative analysis of two rates - PubMed 100 2022-05-24 02:18:35 charles888
    Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study - PubMed 100 2022-05-24 02:17:50 charles888
    Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2 - PubMed 100 2022-05-24 02:16:55 charles888
    Molnupiravir: coding for catastrophe - PubMed 100 2022-05-24 02:16:07 charles888
    Molnupiravir: coding for catastrophe | Nature Structural & Molecular Biology 100 2022-05-24 02:15:29 charles888
    Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template - PubMed 100 2022-05-24 02:15:07 charles888
    Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis - PubMed 100 2022-05-24 02:14:19 charles888
    Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis | Nature Structural & Molecular Biology 100 2022-05-24 02:13:40 charles888
    β-d- N 4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome - PubMed 100 2022-05-24 02:13:21 charles888
    Small-Molecule Antiviral β-d- N 4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance - PubMed 100 2022-05-24 02:12:31 charles888
    Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model - PubMed 100 2022-05-24 02:11:45 charles888
    Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model | The Journal of Infectious Diseases | Oxford Academic 100 2022-05-24 02:11:12 charles888
    SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 - PubMed 100 2022-05-24 02:10:51 charles888
    An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice - PubMed 100 2022-05-24 02:09:52 charles888
    Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets - PubMed 100 2022-05-24 02:09:04 charles888
    Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets | Nature Microbiology 100 2022-05-24 02:08:25 charles888
    Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses - PubMed 100 2022-05-24 02:08:02 charles888
    Outpatient Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection to Prevent Coronavirus Disease 2019 Progression - PubMed 100 2022-05-24 02:07:14 charles888
    Outpatient Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection to Prevent Coronavirus Disease 2019 Progression | Clinical Infectious Diseases | Oxford Academic 100 2022-05-24 02:06:36 charles888
    Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab - PubMed 100 2022-05-24 02:06:15 charles888
    Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab | NEJM 100 2022-05-24 02:05:41 charles888
    Neutralizing Antibody Therapeutics for COVID-19 - PubMed 100 2022-05-24 02:05:22 charles888
    Viruses | Free Full-Text | Neutralizing Antibody Therapeutics for COVID-19 100 2022-05-24 02:05:03 charles888
    Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19 | NEJM Evidence 100 2022-05-24 02:04:44 charles888
    Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 - March 29, 2021 - PubMed 100 2022-05-24 02:04:23 charles888
    Full article: Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 – March 29, 2021 100 2022-05-24 02:03:39 charles888
    Vaccine nationalism and the dynamics and control of SARS-CoV-2 - PubMed 100 2022-05-24 02:03:19 charles888
    Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020 - PubMed 100 2022-05-24 02:02:25 charles888
    Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020 | MMWR 100 2022-05-24 02:01:50 charles888
    Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System - PubMed 100 2022-05-24 02:01:28 charles888
    Risk Factors for Coronavirus Disease 2019 (COVID-19)–Associated Hospitalization: COVID-19–Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System | Clinical Infectious Diseases | Ox 100 2022-05-24 02:00:51 charles888
    Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020 - PubMed 100 2022-05-24 02:00:30 charles888
    Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020 | MMWR 100 2022-05-24 01:59:50 charles888
    Clinical Spectrum of Primaquine-induced Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficiency: A 9-Year Hospitalization-based Study From the Brazilian Amazon - PubMed 100 2022-05-24 01:45:46 charles888
    Clinical Spectrum of Primaquine-induced Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficiency: A 9-Year Hospitalization-based Study From the Brazilian Amazon | Clinical Infectious Diseases | Oxford Academic 100 2022-05-24 01:45:11 charles888
    Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency ( G6PD Mahidol Variant) versus G6PD-Normal Volunteers - PubMed 100 2022-05-24 01:44:49 charles888
    Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date - PubMed 100 2022-05-24 01:37:42 charles888
    Tafenoquine and its potential in the treatment and relapse prevention | DDDT 100 2022-05-24 01:37:09 charles888
    Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru - PubMed 100 2022-05-24 01:36:48 charles888
    The first Plasmodium vivax relapses of life are usually genetically homologous - PubMed 100 2022-05-24 01:35:50 charles888
    Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites - PubMed 100 2022-05-24 01:34:53 charles888
    Relapses of Plasmodium vivax Infection Usually Result from Activation of Heterologous Hypnozoites | The Journal of Infectious Diseases | Oxford Academic 100 2022-05-24 01:34:18 charles888
    Distribution of CYP2D6 alleles and phenotypes in the Brazilian population - PubMed 100 2022-05-24 01:33:55 charles888
    Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population | PLOS ONE 100 2022-05-24 01:33:18 charles888
    The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype - PubMed 100 2022-05-24 01:32:56 charles888
    Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group - PubMed 100 2022-05-24 01:32:10 charles888
    Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping - PubMed 100 2022-05-24 01:31:22 charles888
    Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping | The Journal of Infectious Diseases | Oxford Academic 100 2022-05-24 01:30:47 charles888
    Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum - PubMed 100 2022-05-24 01:30:21 charles888
    Microsatellite Markers Reveal a Spectrum of Population Structures in the Malaria Parasite Plasmodium falciparum | Molecular Biology and Evolution | Oxford Academic 100 2022-05-24 01:29:47 charles888
    Microsatellite variation, repeat array length, and population history of Plasmodium vivax - PubMed 100 2022-05-24 01:29:23 charles888
    Microsatellite Variation, Repeat Array Length, and Population History of Plasmodium vivax | Molecular Biology and Evolution | Oxford Academic 100 2022-05-24 01:28:47 charles888
    Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with a HPLC-DAD method - PubMed 100 2022-05-24 01:28:22 charles888
    Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with a HPLC-DAD method | Malaria Journal | Full Text 100 2022-05-24 01:27:46 charles888
    Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria - PubMed 100 2022-05-24 01:27:26 charles888
    Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria | NEJM 100 2022-05-24 01:26:50 charles888
    Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil - PubMed 100 2022-05-24 01:26:29 charles888
    Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil in: The American Journal of Tropical Medicine and Hygiene Volume 95 Issue 5 (2016) 100 2022-05-24 01:25:55 charles888
    Primaquine resistance in Plasmodium vivax - PubMed 100 2022-05-24 01:25:31 charles888
    Primaquine Resistance in Plasmodium vivax in: The American Journal of Tropical Medicine and Hygiene Volume 55 Issue 3 (1996) 100 2022-05-24 01:24:59 charles888
    Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I - PubMed 100 2022-05-24 01:24:34 charles888
    PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I in: The American Journal of Tropical Medicine and Hygiene Volume 75 Issue 3 (2006) 100 2022-05-24 01:23:59 charles888
    Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria - PubMed 100 2022-05-24 01:23:33 charles888